We are live on
!
Find out more
IAP
Indie Asset Partners Portfolio holdings
AUM
$87.8M
1-Year Est. Return
27.76%
This Fund
S&P 500
This Quarter
Est. Return
+12.79%
1 Year Est. Return
+27.76%
3 Year Est. Return
+120.76%
5 Year Est. Return
+150.7%
10 Year Est. Return
–
AUM
$85.9M
AUM Growth
+$6.07M
(+7.6%)
Cap. Flow
-$2.29M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
45.9%
Holding
119
New
26
Increased
15
Reduced
64
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADC Therapeutics
ADCT
|
+$3.02M |
| 2 |
BLCN
Siren ETF Trust Siren NexGen Economy ETF
BLCN
|
+$2.08M |
| 3 |
Commault Systems
CVLT
|
+$667K |
| 4 |
Intercontinental Exchange
ICE
|
+$525K |
| 5 |
Global X Lithium & Battery Tech ETF
LIT
|
+$515K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short S&P500
SH
|
+$2.29M |
| 2 |
Microsoft
MSFT
|
+$1.13M |
| 3 |
BlackRock Municipal 2030 Target Term Trust
BTT
|
+$1.1M |
| 4 |
Apple
AAPL
|
+$833K |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$768K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.09% |
| 2 | Technology | 15.8% |
| 3 | Consumer Discretionary | 8.16% |
| 4 | Communication Services | 5.61% |
| 5 | Financials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Lumen
LUMN
$6.09B
| $213K | 0.25% |
21,800
+1,800
| +9% | +$17.8K |
|
102
CVS Health
CVS
$123B
| $210K | 0.24% |
+3,068
| New | +$200K |
|
103
Gilead Sciences
GILD
$162B
| $209K | 0.24% |
3,582
-2,313
| -39% | -$140K |
|
104
Fastenal
FAST
$58.3B
| $208K | 0.24% |
+8,520
| New | +$201K |
|
105
Editas Medicine
EDIT
$445M
| $207K | 0.24% |
+2,950
| New | +$121K |
|
106
W.W. Grainger
GWW
$60.4B
| $207K | 0.24% |
+508
| New | +$200K |
|
|
QTNT
107
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $117K | 0.14% |
563
| – | – |
|
108
MiMedx Group
MDXG
$609M
| $111K | 0.13% |
+12,200
| New | +$87.8K |
|
109
SiriusXM
SIRI
$10.1B
| $70K | 0.08% |
1,100
-49
| -4% | -$3.01K |
|
110
DTE Energy
DTE
$29.1B
| – | – |
-2,366
| Closed | -$232K |
|
111
Kohl's
KSS
$2.09B
| – | – |
-10,250
| Closed | -$190K |
|
112
McCormick & Company Non-Voting
MKC
$14.1B
| – | – |
-5,536
| Closed | -$537K |
|
|
113
ProShares Short S&P500
SH
$902M
| – | – |
-28,113
| Closed | -$2.29M |
|
114
Tesla
TSLA
$1.26T
| – | – |
-1,401
| Closed | -$200K |
|
115
United Parcel Service
UPS
$87.7B
| – | – |
-1,391
| Closed | -$232K |
|
116
Vanguard Morningstar Growth ETF
VUG
$229B
| – | – |
-6,282
| Closed | -$238K |
|
117
Vanguard High Dividend Yield ETF
VYM
$82.3B
| – | – |
-2,970
| Closed | -$240K |
|
118
Zoom
ZM
$29.7B
| – | – |
-428
| Closed | -$201K |
|
|
BFO
119
DELISTED
Blackrock Florida Municipal 2020 Term Trust
BFO
| – | – |
-35,000
| Closed | -$516K |
|
Similar funds
DG
XXIP
CVM
BCP
PM
PBCM
IC
RFL
Indie Asset Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Indie Asset Partners held 119 positions worth $85.9M, up 7.6% from $79.8M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Indie Asset Partners's Q4 2020 filing shows 26 new, 15 increased, 64 reduced and 10 closed positions. Its largest new stake was ADC Therapeutics: 92,287 shares worth $2.95M. The largest sale was ProShares Short S&P500, an estimated $2.29M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Indie Asset Partners's largest Q4 2020 buy was ADC Therapeutics: 92,287 shares worth $2.95M.
- Indie Asset Partners added most to American Tower in Q4 2020, an estimated $498K increase.
- Indie Asset Partners's biggest Q4 2020 reduction was Microsoft, cutting an estimated $1.13M.
- Indie Asset Partners fully exited ProShares Short S&P500 in Q4 2020, selling an estimated $2.29M.
- Indie Asset Partners's ten largest holdings make up 46% of its $85.9M portfolio in Q4 2020.
- Indie Asset Partners opened 26 new positions and closed 10 in Q4 2020.
- Indie Asset Partners's portfolio value rose 7.6% quarter-over-quarter to $85.9M.
Based on Indie Asset Partners's 13F filing for Q4 2020, filed 9 Feb 2021.